Jacobio Pharmaceuticals Group Co., Ltd.

OTCPK:JBPH.F Stock Report

Market Cap: US$189.7m

Jacobio Pharmaceuticals Group Management

Management criteria checks 4/4

Jacobio Pharmaceuticals Group's CEO is Yinxiang Wang, appointed in Aug 2019, has a tenure of 4.75 years. total yearly compensation is CN¥3.42M, comprised of 77.3% salary and 22.7% bonuses, including company stock and options. directly owns 13.58% of the company’s shares, worth $25.78M. The average tenure of the management team and the board of directors is 4.3 years and 4.8 years respectively.

Key information

Yinxiang Wang

Chief executive officer

CN¥3.4m

Total compensation

CEO salary percentage77.3%
CEO tenure4.8yrs
CEO ownership13.6%
Management average tenure4.3yrs
Board average tenure4.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Yinxiang Wang's remuneration changed compared to Jacobio Pharmaceuticals Group's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023CN¥3mCN¥3m

-CN¥359m

Sep 30 2023n/an/a

-CN¥385m

Jun 30 2023n/an/a

-CN¥410m

Mar 31 2023n/an/a

-CN¥391m

Dec 31 2022CN¥4mCN¥2m

-CN¥372m

Sep 30 2022n/an/a

-CN¥332m

Jun 30 2022n/an/a

-CN¥292m

Mar 31 2022n/an/a

-CN¥297m

Dec 31 2021CN¥4mCN¥2m

-CN¥301m

Compensation vs Market: Yinxiang's total compensation ($USD472.74K) is below average for companies of similar size in the US market ($USD1.55M).

Compensation vs Earnings: Yinxiang's compensation has been consistent with company performance over the past year.

CEO

Yinxiang Wang (58 yo)

4.8yrs

Tenure

CN¥3,415,000

Compensation

Dr. Yinxiang Wang serves as Consultant at Shining Capital. He is an Executive Chairman at Jacobio Pharmaceuticals Co. Ltd. since August 20, 2020.Dr. Wang has been Director at Jacobio Pharmaceuticals Co. L...

Leadership Team

NamePositionTenureCompensationOwnership
Yinxiang Wang
Executive Chairman & CEO4.8yrsCN¥3.42m13.58%
$ 25.8m
Xiaojie Wang
Executive Director & President of Administration8.7yrsCN¥2.55m2.9%
$ 5.5m
Yunyan Hu
Executive VP & Executive Director5.2yrsCN¥2.51m2.94%
$ 5.6m
Tao Yang
Vice President of Human Resourcesno datano datano data
Andrea Wang-Gillam
Executive VP3.8yrsno datano data
Yanping Wang
Executive Vice President of Non-Clinical R&Dno datano datano data
Haijun Wang
Senior Vice President of Information & Data Managementno datano datano data
Wei Long
Head of Drug Discoveryno datano datano data
Yuli Ding
Executive Vice President of Clinical Developmentno datano datano data
Qing Xue
Joint Company Secretary3.8yrsno datano data
Ming Fai Chung
Joint Company Secretary1.8yrsno datano data

4.3yrs

Average Tenure

55yo

Average Age

Experienced Management: JBPH.F's management team is considered experienced (4.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Yinxiang Wang
Executive Chairman & CEO5.9yrsCN¥3.42m13.58%
$ 25.8m
Xiaojie Wang
Executive Director & President of Administration5.8yrsCN¥2.55m2.9%
$ 5.5m
Yunyan Hu
Executive VP & Executive Director5.8yrsCN¥2.51m2.94%
$ 5.6m
Yanmin Tang
Non-Executive Director5.8yrsno datano data
Ge Wu
Independent Non-Executive Director3.8yrsCN¥200.00kno data
Ruilin Song
Independent Non-Executive Director3.8yrsCN¥400.00kno data
Te-li Chen
Non Executive Director3.8yrsno datano data
Bai Lu
Independent Non-Executive Director1.2yrsCN¥150.00kno data

4.8yrs

Average Tenure

58yo

Average Age

Experienced Board: JBPH.F's board of directors are considered experienced (4.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/05/19 19:44
End of Day Share Price 2024/02/20 00:00
Earnings2023/12/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Jacobio Pharmaceuticals Group Co., Ltd. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ziyi ChenGoldman Sachs